Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Macrogenics (MGNX) Gross Margin (2020 - 2025)

Historic Gross Margin for Macrogenics (MGNX) over the last 6 years, with Q3 2025 value amounting to 100.0%.

  • Macrogenics' Gross Margin rose 1500.0% to 100.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 99.84%, marking a year-over-year increase of 4200.0%. This contributed to the annual value of 99.44% for FY2024, which is 4900.0% up from last year.
  • As of Q3 2025, Macrogenics' Gross Margin stood at 100.0%, which was up 1500.0% from 100.0% recorded in Q2 2025.
  • In the past 5 years, Macrogenics' Gross Margin registered a high of 100.0% during Q1 2025, and its lowest value of 89.37% during Q3 2021.
  • For the 5-year period, Macrogenics' Gross Margin averaged around 97.91%, with its median value being 99.42% (2024).
  • In the last 5 years, Macrogenics' Gross Margin plummeted by -106300bps in 2021 and then soared by 65400bps in 2022.
  • Quarter analysis of 5 years shows Macrogenics' Gross Margin stood at 93.31% in 2021, then rose by 7bps to 99.84% in 2022, then decreased by -1bps to 98.48% in 2023, then increased by 1bps to 99.42% in 2024, then rose by 1bps to 100.0% in 2025.
  • Its last three reported values are 100.0% in Q3 2025, 100.0% for Q2 2025, and 100.0% during Q1 2025.